Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04170556
Title Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING) (GOING)
Acronym GOING
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Fundacion Clinic per a la Recerca Biomedica
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.